Dr. Jolene Berg

Family Medicine
Office
308 Dearborn Ct, 
Hopkins, MN 
Office
308 Dearborn Ct, 
Hopkins, MN 

Overview

Jolene Berg is a primary care provider, practicing in Family Medicine in Hopkins, Minnesota.

Her clinical expertise encompasses Chronic Kidney Disease, Type 2 Diabetes (T2D), and End-Stage Renal Disease (ESRD).

She is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 8 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in MN

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
308 Dearborn Ct, Hopkins, MN 55343

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Enrollment Status: Completed
Publish Date: February 02, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on the Single-Dose Pharmacokinetics of Sitravatinib
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on the Single-Dose Pharmacokinetics of Sitravatinib
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Subjects With Severely Impaired Renal Function
A Phase 1, Open-label, Single-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Subjects With Severely Impaired Renal Function
Enrollment Status: Completed
Publish Date: June 23, 2022
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of MEK162 in Subjects With Mild, Moderate and Severe Hepatic Impairment
A Phase I, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of MEK162 in Subjects With Mild, Moderate and Severe Hepatic Impairment
Enrollment Status: Terminated
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects
Enrollment Status: Completed
Publish Date: February 18, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

16 Total Publications

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.
Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.
Journal: Journal of clinical pharmacology
Published: April 26, 2023
Similar Doctors
Expertise in
10
conditions
Dr. David Ross
Family Medicine
Expertise in
10
conditions
Dr. David Ross
Family Medicine

Park Nicollet Clinic Wayzata

250 Central Ave N Ste 103, 
Wayzata, MN 
 (7.7 miles away)
844-425-2932
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Ross is a primary care provider, practicing in Family Medicine in Wayzata, Minnesota. Dr. Ross is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Myelofibrosis, Leukemia, Essential Thrombocythemia, and Endoscopy.

Expertise in
9
conditions
Dr. Won Choi
Family Medicine
Expertise in
9
conditions
Dr. Won Choi
Family Medicine

M. Health Fairview Eden Prairie Clinic

830 Prairie Center Dr, 
Eden Prairie, MN 
 (4.7 miles away)
952-826-6500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Won Choi is a primary care provider, practicing in Family Medicine in Eden Prairie, Minnesota. Dr. Choi is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Flu, Shingles, Avian Influenza, COVID-19, and Endoscopy.

Expertise in
6
conditions
Dr. John Hokanson
Family Medicine
Expertise in
6
conditions
Dr. John Hokanson
Family Medicine

HealthPartners Clinic Stillwater

1500 Curve Crest Blvd W, 
Stillwater, MN 
 (28.7 miles away)
651-467-5297
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Hokanson is a primary care provider, practicing in Family Medicine in Stillwater, Minnesota. Dr. Hokanson is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Coronary Heart Disease, and Type 1 Diabetes (T1D).

Frequently Asked Questions about Dr. Jolene Berg

How do I make an appointment with Dr. Jolene Berg?

You can book an appointment with Dr. Jolene Berg by calling their office at 612-718-8984. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jolene Berg a top-rated expert for Chronic Kidney Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jolene Berg is classified as an Experienced expert for Chronic Kidney Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jolene Berg specialize in?

While Dr. Jolene Berg is a Family Medicine, they have specific expertise in Chronic Kidney Disease, Type 2 Diabetes (T2D), and End-Stage Renal Disease (ESRD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Jolene Berg participate in research or clinical trials?

Yes. Dr. Jolene Berg has published 16 articles and abstracts on conditions like Chronic Kidney Disease. You can view a list of Dr. Jolene Berg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Berg's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile